Patents by Inventor Lendell L. Cummins

Lendell L. Cummins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170275622
    Abstract: Provided herein are compositions and methods for the alteration of neuronal methylation by synthetic piRNAs or by alteration of piRNA function. Such alterations find use in the regulation and control of neural gene expression and concomitant neural functions. Further provided herein are systems and methods for the identification of target sites for regulation by piRNAs.
    Type: Application
    Filed: March 27, 2017
    Publication date: September 28, 2017
    Inventors: David J. Ecker, Todd P. Michael, Lendell L. Cummins, Mark W. Eshoo, Stanley T. Motley, Danny M. Chou
  • Patent number: 9605260
    Abstract: Provided herein are compositions and methods for the alteration of neuronal methylation by synthetic piRNAs or by alteration of piRNA function. Such alterations find use in the regulation and control of neural gene expression and concomitant neural functions. Further provided herein are systems and methods for the identification of target sites for regulation by piRNAs.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: March 28, 2017
    Assignee: IBIS BIOSCIENCES, INC.
    Inventors: David J. Ecker, Todd P. Michael, Lendell L. Cummins, Mark W. Eshoo, Stanley T. Motley, Danny M. Chou
  • Publication number: 20160122810
    Abstract: Provided herein are methods for improving the detection sensitivity of amplification reaction products. In particular, provided herein are methods of improving sensitivity of detection of amplification products by introducing modified and degradable nucleotides into amplification primers.
    Type: Application
    Filed: October 22, 2015
    Publication date: May 5, 2016
    Inventors: Thomas N. Chiesl, Steven G. Haupt, Lendell L. Cummins, Christopher D. Crowder
  • Publication number: 20140275216
    Abstract: Provided herein are compositions and methods for the alteration of neuronal methylation by synthetic piRNAs or by alteration of piRNA function. Such alterations find use in the regulation and control of neural gene expression and concomitant neural functions. Further provided herein are systems and methods for the identification of target sites for regulation by piRNAs.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Applicant: IBIS Biosciences, Inc.
    Inventors: David J. Ecker, Todd P. Michael, Lendell L. Cummins, Mark W. Eshoo, Stanley T. Motley, Danny M. Chou
  • Patent number: 8476415
    Abstract: The present invention provides a method for rapid solution capture purification of nucleic acids for subsequent analysis by electrospray mass spectrometry which is efficient and cost-effective relative to existing methods. The present invention also provides kits useful for practicing rapid solution capture of nucleic acids so that purified samples are in condition for analysis by electrospray mass spectrometry.
    Type: Grant
    Filed: April 16, 2012
    Date of Patent: July 2, 2013
    Assignee: Ibis Biosciences, Inc.
    Inventors: Steven A. Hofstadler, Lendell L. Cummins
  • Publication number: 20120207655
    Abstract: The present invention provides a method for rapid solution capture purification of nucleic acids for subsequent analysis by electrospray mass spectrometry which is efficient and cost-effective relative to existing methods. The present invention also provides for kits useful for practicing rapid solution capture of nucleic acids so that purified samples are in condition for analysis by electrospray mass spectrometry.
    Type: Application
    Filed: April 16, 2012
    Publication date: August 16, 2012
    Applicant: IBIS BIOSCIENCES, INC.
    Inventors: Steven A. Hofstadler, Lendell L. Cummins
  • Patent number: 8158354
    Abstract: The present invention provides a method for rapid solution capture purification of nucleic acids for subsequent analysis by electrospray mass spectrometry which is efficient and cost-effective relative to existing methods. The present invention also provides kits useful for practicing rapid solution capture of nucleic acids so that purified samples are in condition for analysis by electrospray mass spectrometry.
    Type: Grant
    Filed: September 17, 2004
    Date of Patent: April 17, 2012
    Assignee: Ibis Biosciences, Inc.
    Inventors: Steven A. Hofstadler, Lendell L. Cummins
  • Patent number: 7964343
    Abstract: The present invention provides a method for rapid solution capture purification of nucleic acids for subsequent analysis by electrospray mass spectrometry which is efficient and cost-effective relative to existing methods. The present invention also provides kits useful for practicing rapid solution capture of nucleic acids so that purified samples are in condition for analysis by electrospray mass spectrometry.
    Type: Grant
    Filed: May 12, 2004
    Date of Patent: June 21, 2011
    Assignee: Ibis Biosciences, Inc.
    Inventors: Steven A. Hofstadler, Lendell L. Cummins
  • Publication number: 20100190240
    Abstract: Embodiments of the present invention provide methods and kits for purifying nucleic acids. In particular, embodiments of the present invention provide methods and kits for purifying nucleic acids through the use of magnetic particles in binding buffers.
    Type: Application
    Filed: March 21, 2008
    Publication date: July 29, 2010
    Inventors: Yun Jiang, Lendell L. Cummins, Steven A. Hofstadler
  • Patent number: 6127124
    Abstract: Methods for the determination of nuclease stability of an oligomeric compound and its deletion sequences by capillary gel electrophoresis using laser-induced fluorescence detection (LIF CGE) are provided. Fluorescently labeled oligomeric compounds are treated with one or more agents having nuclease activity resulting in an assay mixture of the original oligomeric compound and its deletion sequences. A diluted aliquot taken directly from the assay mixture is analyzed using LIF CGE. Results of the assay yield quantitative concentrations of the oligomeric compound and each of the deletion sequences. In further embodiments, the invention provides methods for determining the relative binding affinity of one or more oligomeric compounds for a substrate having nuclease activity, and methods for determining the nuclease activity of an enzyme.
    Type: Grant
    Filed: January 20, 1999
    Date of Patent: October 3, 2000
    Assignee: Isis Pharmaceuticals, Inc.
    Inventors: Janet M. Leeds, Lendell L. Cummins
  • Patent number: 6045995
    Abstract: Methods are provided for detection and quantitation of mixtures containing target nucleobase sequences using capillary electrophoresis. Peptide nucleic acid oligomers, complementary to the target sequences and preferably having appended detectable labels, are hybridized to the targets. Capillary electrophoresis is then performed, and the detectable label is detected and quantitated.
    Type: Grant
    Filed: August 24, 1994
    Date of Patent: April 4, 2000
    Assignee: Isis Pharmaceuticals, Inc.
    Inventors: Lendell L. Cummins, Susan M. Freier, Richard Griffey, G. Susan Srivatsa
  • Patent number: 5874213
    Abstract: Methods are provided for detection and quantitation of mixtures containing target nucleobase sequences using capillary electrophoresis. Peptide nucleic acid oligomers, complementary to the target sequences and preferably having appended detectable labels, are hybridized to the targets. Capillary electrophoresis is then performed, and the detectable label is detected and quantitated.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: February 23, 1999
    Assignee: Isis Pharmacueticals, Inc.
    Inventors: Lendell L. Cummins, Susan M. Freier, Richard Griffey, G. Susan Srivatsa